How to diagnose and correct iron deficiency during r-huEPO therapy - A consensus report

被引:86
作者
Horl, WH
Cavill, I
Macdougall, IC
Schaefer, RM
SunderPlassmann, G
机构
关键词
D O I
10.1093/oxfordjournals.ndt.a027248
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:246 / 250
页数:5
相关论文
共 38 条
[1]  
ANASTASSIADES EG, 1993, NEPHROL DIAL TRANSPL, V8, P846
[2]   ARE BODY IRON STORES RELATED TO THE RISK OF CORONARY HEART-DISEASE [J].
ASCHERIO, A ;
WILLETT, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (16) :1152-1154
[3]  
BARANY P, 1995, PERITON DIALYSIS INT, V15, P54
[4]  
BONNAR J, 1969, LANCET, V1, P457
[5]  
CAVILL I, 1982, CLIN HAEMATOL, V2, P259
[6]   THE RATIONALE FOR TREATING IRON-DEFICIENCY ANEMIA [J].
CROSBY, WH .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (03) :471-472
[7]   INTRADIALYTIC ORAL IRON THERAPY [J].
DUNEA, G ;
SWAGEL, MA ;
BODIWALA, U ;
ARRUDA, JAL .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (05) :261-264
[8]  
ESCHBACH JW, 1989, CONTRIB NEPHROL, V76, P160
[9]  
FALLER B, 1993, CLIN NEPHROL, V40, P168
[10]   THE UTILITY OF ZINC PROTOPORPHYRIN FOR PREDICTING THE NEED FOR INTRAVENOUS IRON THERAPY IN HEMODIALYSIS-PATIENTS [J].
FISHBANE, S ;
LYNN, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) :426-432